Novo Nordisk's (NVO) third-quarter earnings were solid enough to soothe investor jitters and turn the market's attention toward upcoming trial results for a potentially game-changing new weight-loss ...

Reforming Europe's economy is all the more urgent following Donald Trump's US election win, warned the author of a ...

Europe must make radical reforms and ramp up investment to catch up with the United States or face a painful decline: that is the message of a report by former European Central Bank chief Mario Draghi ...

Global stock markets are set to end the week on a strong note amid the US election and China's highly anticipated additional ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

EUROPEAN shares ended lower on Wednesday, following a broad rally earlier in the session, hurt by a drop in utilities shares on fears that US President-elect Donald Trump could halt fresh approvals ...

European shares ended lower on Wednesday, following a broad rally earlier in the session, hurt by a drop in utilities shares ...

Sales of Novo Nordisk’s (NVO) blockbuster weight loss drug Wegovy continue to soar, surpassing Wall Street expectations. The ...

The former U.S. President had vowed to impose a 10% tariff on imports from all countries if he won, and said the European ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor ...

We recently compiled a list of the 8 Best European Stocks To Buy According to Hedge Funds. In this article, we are going to ...

BRUSSELS/LONDON (Reuters) -EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of ...